Insights & Resources

KPMG has released their 2024 biopharma report detailing the challenges and opportunities for pharma companies moving forward into the new year.

The medical technology, or medtech, industry is poised for a transformative year despite soft IPO activity the first half of 2024. Learn more here.

The biopharma industry has experienced a resurgence the first part of 2024. J.P. Morgan’s Q2 report shares critical insights into the future of the industry.

Facing limited resources and increasingly rapid technology advances, public service organizations must evolve their processes, systems and infrastructure to embrace existing shifts.

Cybersecurity is critically important, especially for school districts. For educators, an understanding of cybersecurity’s best practices cannot be overstated.

Ensure your school district's financial transparency and compliance. Discover strategies to avoid common deficiencies in AFR and ACFR reviews.

Discover the key elements of GASB 103, Financial Reporting Model Improvement, which enhances financial reporting consistency and will go into effect on June 15, 2025.

The DOE has introduced a national definition of a zero emissions building, setting clear criteria for energy-efficient buildings to reduce greenhouse gas emissions.

New GASB requirements affecting government entities include financial reporting improvements and classification of nonfinancial assets.

Unravel life sciences industry complexities, and discover the differences between FDA special review designations like Fast Track, Priority Review and Breakthrough.

The credit is aimed at bolstering and incentivizing the emerging biotechnology sector to create jobs and invest in NYC and is available 1/1/23-1/1/26.

Change Healthcare was impacted by a cybersecurity incident that breached its information technology network.